Want to see IN:BIOCON full AI Analyst Report?
Biocon Limited (BIOCON) Revenue
Biocon Limited Revenue
Biocon Limited had a revenue of 43.36B in the quarter ending Jun 30, 2026, with -4.00%. This bring the company's revenue in the last twelve months to 172.88B, Increased 2.33%. In the fiscal year ending Mar 31, 2026, Biocon Limited had annual revenue of 169.27B with 10.91% growth.
- Revenue (ttm)
- 172.88B
- Revenue Growth
- 9.83%
- P/S Ratio
- 3.39
- Revenue/Employee
- INR 10,291,847
- Employees
- 16,447
- Market Cap
- INR 573.10B
Revenue Chart
Biocon Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 169.27B | 16.65B | 10.91% |
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.81B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
| Mar 31, 2020 | 63.01B | 7.86B | 14.26% |
| Mar 31, 2019 | 55.14B | 13.91B | 33.73% |
| Mar 31, 2018 | 41.23B | 2.32B | 5.97% |
| Mar 31, 2017 | 38.91B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:BIOCON | 172.88B |
| IN:CONCORDBIO | 11.08B |
| IN:DCAL | 22.92B |
| IN:PANACEABIO | 6.73B |
| IN:SYNGENE | 36.00B |
| IN:ANTHEM | 10.33B |